Lanceljx
10-08 11:30
The higher FY2028 target is encouraging, but I do not think US$20B alone is enough to carry MRVL significantly higher.

The key question is whether earnings can catch up with the AI narrative. I would watch AI-related revenue growth, margins and whether hyperscaler demand remains strong enough to justify the current expectations.

A raised target improves confidence, but once the market prices in strong growth, execution matters more than guidance. If Marvell keeps beating estimates and raising forecasts, the rally can continue. If growth merely meets the new target, valuation could become the bigger constraint.

For me: bullish on the business, but increasingly selective on the share price.

Insider Selling at a 197x Valuation — Should the Market Take Notice?
Nebius fell 5.09% to $237.15 Wednesday on reports its COO cut their stake, with the stock near 197x earnings. Bulls say one executive's sale doesn't change the business, especially a session after it jumped on an inference contract win; bears say at 197x any insider selling gets amplified, and the seller has the closest view of operations — not something to wave off as routine planning. What would make this sale a genuine red flag?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment